These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20856594)

  • 1. Difluprednate ophthalmic emulsion 0.05% (Durezol) administered two times daily for managing ocular inflammation and pain following cataract surgery.
    Smith S; Lorenz D; Peace J; McLeod K; Crockett RS; Vogel R
    Clin Ophthalmol; 2010 Sep; 4():983-91. PubMed ID: 20856594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Korenfeld MS; Silverstein SM; Cooke DL; Vogel R; Crockett RS;
    J Cataract Refract Surg; 2009 Jan; 35(1):26-34. PubMed ID: 19101421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
    Wilson ME; O'Halloran H; VanderVeen D; Roarty J; Plager DA; Markwardt K; Gedif K; Lambert SR
    Eye (Lond); 2016 Sep; 30(9):1187-94. PubMed ID: 27367745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis.
    Foster CS; Davanzo R; Flynn TE; McLeod K; Vogel R; Crockett RS
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):475-83. PubMed ID: 20809807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery.
    Abessi B; Brooksby L; Schultze RL
    Eye Contact Lens; 2018 Nov; 44 Suppl 2():S37-S42. PubMed ID: 28628490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To Study the Efficacy of Difluprednate Ophthalmic Emulsion and Prednisolone Acetate Ophthalmic Suspension on Post-operative Inflammation in Cataract Surgery.
    Garg P; Tuteja N; Qayum S
    J Clin Diagn Res; 2016 Dec; 10(12):NC05-NC08. PubMed ID: 28208898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Efficacy of Difluprednate 0.05% Versus Prednisolone Acetate 1% in Controlling Inflammation and Macular Oedema Following Phacoemulsification: An Optical Coherence Tomography-Based Study.
    Panda BB; Nanda A; Swain SC
    Cureus; 2021 Apr; 13(4):e14673. PubMed ID: 34055520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial.
    Palacio-Pastrana C; Chávez-Mondragón E; Soto-Gómez A; Suárez-Velasco R; Montes-Salcedo M; Fernández de Ortega L; Nasser-Nasser L; Baiza-Durán L; Olvera-Montaño O; Muñoz-Villegas P
    Clin Ophthalmol; 2020; 14():1581-1589. PubMed ID: 32606573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difluprednate versus Prednisolone Acetate after Cataract Surgery: a Systematic Review and Meta-Analysis.
    KhalafAllah MT; Basiony A; Salama A
    BMJ Open; 2019 Nov; 9(11):e026752. PubMed ID: 31678934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.
    Verhoeven RS; Garcia A; Robeson R; Gilger BC; Culp D; Struble C; Hamm L; Navratil T; Yerxa B
    J Ocul Pharmacol Ther; 2018; 34(1-2):161-169. PubMed ID: 28650720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension.
    Tijunelis MA; Person E; Niziol LM; Musch DC; Ernest P; McBain M; Mian SI
    J Cataract Refract Surg; 2017 Feb; 43(2):223-227. PubMed ID: 28366370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
    Walters TR; Goldberg DF; Peace JH; Gow JA;
    Ophthalmology; 2014 Jan; 121(1):25-33. PubMed ID: 24021896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery.
    Donnenfeld ED; Holland EJ; Solomon KD; Fiore J; Gobbo A; Prince J; Sandoval HP; Shull ER; Perry HD
    Am J Ophthalmol; 2011 Oct; 152(4):609-617.e1. PubMed ID: 21704965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
    Maxwell WA; Reiser HJ; Stewart RH; Cavanagh HD; Walters TR; Sager DP; Meuse PA
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):593-9. PubMed ID: 19040348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
    Henderson BA; Gayton JL; Chandler SP; Gow JA; Klier SM; McNamara TR;
    Ophthalmology; 2011 Nov; 118(11):2120-7. PubMed ID: 21762992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies.
    Fong R; Cavet ME; DeCory HH; Vittitow JL
    Clin Ophthalmol; 2019; 13():1427-1438. PubMed ID: 31447544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
    Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
    Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure elevation from topical difluprednate use.
    Meehan K; Vollmer L; Sowka J
    Optometry; 2010 Dec; 81(12):658-62. PubMed ID: 21111374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery.
    Comstock TL; Paterno MR; Singh A; Erb T; Davis E
    Clin Ophthalmol; 2011; 5():177-86. PubMed ID: 21383946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.
    Sheppard JD; Toyos MM; Kempen JH; Kaur P; Foster CS
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2993-3002. PubMed ID: 24677110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.